Shareholding for the Period Ended September 30, 2016
Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here18-10-2016
18-10-2016
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Gufic Biosciences Ltd has informed BSE regarding the details of Voting results at the 32nd Annual General Meeting (AGM) of the Company held on September 28, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report.30-09-2016
Outcome of AGM
Gufic Biosciences Ltd has informed BSE that the 32nd Annual General Meeting (AGM) of the Company was held on September 28, 2016.29-09-2016
Statement on Impact of Audit Qualifications for the period ended March 31, 2016
Gufic Biosciences Ltd has submitted to BSE a copy of Standalone Statement on Impact of Audit Qualifications for the period ended March 31, 2016.22-09-2016
Newspaper cutting of published Notice of AGM, Book closure and Remote E-voting
Gufic Biosciences Ltd has submitted to BSE a copy of Newspaper cutting of published Notice of AGM, Book closure and Remote E-voting.16-09-2016
AGM on Sept 28, 2016
Gufic Biosciences Ltd has informed BSE that the 32nd Annual General Meeting (AGM) of the Company will be held on September 28, 2016.07-09-2016
Fixes Book Closure for Dividend & AGM
Gufic Biosciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2016 to September 28, 2016 (both days inclusive) for the purpose of Payment of Dividend & 32nd Annual General Meeting (AGM) of the Company to be held on September 28, 2016.07-09-2016
Outcome of Board Meeting
Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2016, inter alia, has approved Re-appointment of Mr. Pankaj J. Gandhi as Whole Time Executive Director of the Company whose term is due to expire on September 06, 2016, for a further term of five years effective from September 07, 2016, subject to the approval of the Members at the ensuing Annual General Meeting.13-08-2016
Standalone Financial Results, Limited Review Report for June 30, 2016
Gufic Biosciences Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 201613-08-2016
Board Meeting Intimation for Results & Closure of Trading Window
Gufic Biosciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on August 12, 2016, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2016.Further, pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of "Code of Conduct Insider Trading"...04-08-2016